title: Duplication of the Ph-chromosome as a possible mechanism of resistance to imatinib mesylate in patients with chronic myelogenous leukemia.
authors.forename: A
authors.initials: A
authors.lastname: Ossard-Receveur
authors.forename: A
authors.initials: A
authors.lastname: Bernheim
authors.forename: B
authors.initials: B
authors.lastname: Clausse
authors.forename: G
authors.initials: G
authors.lastname: Danglot
authors.forename: D
authors.initials: D
authors.lastname: Fauvet
authors.forename: B
authors.initials: B
authors.lastname: Leon
authors.forename: F
authors.initials: F
authors.lastname: Lozach
authors.forename: D
authors.initials: D
authors.lastname: Bories
authors.forename: C
authors.initials: C
authors.lastname: Brouzes
authors.forename: J H
authors.initials: JH
authors.lastname: Bourhis
authors.forename: A G
authors.initials: AG
authors.lastname: Turhan
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D002869:Chromosome Aberrations; D019008:Drug Resistance, Neoplasm; D006801:Humans; D000068877:Imatinib Mesylate; D007621:Karyotyping; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics*; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate